SHARPIN is an endogenous inhibitor of β1-integrin activation
Standard
SHARPIN is an endogenous inhibitor of β1-integrin activation. / Rantala, Juha K; Pouwels, Jeroen; Pellinen, Teijo; Veltel, Stefan; Laasola, Petra; Mattila, Elina; Potter, Christopher S; Duffy, Ted; Sundberg, John P; Kallioniemi, Olli; Askari, Janet A; Humphries, Martin J; Parsons, Maddy; Salmi, Marko; Ivaska, Johanna.
In: NAT CELL BIOL, Vol. 13, No. 11, 01.11.2011, p. 1315-24.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - SHARPIN is an endogenous inhibitor of β1-integrin activation
AU - Rantala, Juha K
AU - Pouwels, Jeroen
AU - Pellinen, Teijo
AU - Veltel, Stefan
AU - Laasola, Petra
AU - Mattila, Elina
AU - Potter, Christopher S
AU - Duffy, Ted
AU - Sundberg, John P
AU - Kallioniemi, Olli
AU - Askari, Janet A
AU - Humphries, Martin J
AU - Parsons, Maddy
AU - Salmi, Marko
AU - Ivaska, Johanna
PY - 2011/11/1
Y1 - 2011/11/1
N2 - Regulated activation of integrins is critical for cell adhesion, motility and tissue homeostasis. Talin and kindlins activate β1-integrins, but the counteracting inhibiting mechanisms are poorly defined. We identified SHARPIN as an important inactivator of β1-integrins in an RNAi screen. SHARPIN inhibited β1-integrin functions in human cancer cells and primary leukocytes. Fibroblasts, leukocytes and keratinocytes from SHARPIN-deficient mice exhibited increased β1-integrin activity, which was fully rescued by re-expression of SHARPIN. We found that SHARPIN directly binds to a conserved cytoplasmic region of integrin α-subunits and inhibits recruitment of talin and kindlin to the integrin. Therefore, SHARPIN inhibits the critical switching of β1-integrins from inactive to active conformations.
AB - Regulated activation of integrins is critical for cell adhesion, motility and tissue homeostasis. Talin and kindlins activate β1-integrins, but the counteracting inhibiting mechanisms are poorly defined. We identified SHARPIN as an important inactivator of β1-integrins in an RNAi screen. SHARPIN inhibited β1-integrin functions in human cancer cells and primary leukocytes. Fibroblasts, leukocytes and keratinocytes from SHARPIN-deficient mice exhibited increased β1-integrin activity, which was fully rescued by re-expression of SHARPIN. We found that SHARPIN directly binds to a conserved cytoplasmic region of integrin α-subunits and inhibits recruitment of talin and kindlin to the integrin. Therefore, SHARPIN inhibits the critical switching of β1-integrins from inactive to active conformations.
KW - Animals
KW - Antigens, CD29
KW - Binding Sites
KW - Cell Line, Tumor
KW - Cell Movement
KW - Fibroblasts
KW - Humans
KW - Keratinocytes
KW - Leukocytes
KW - Ligands
KW - Mice
KW - Mice, Inbred C57BL
KW - Mice, Knockout
KW - Mutation
KW - Nerve Tissue Proteins
KW - Protein Conformation
KW - Protein Interaction Domains and Motifs
KW - Protein Interaction Mapping
KW - Protein Subunits
KW - RNA Interference
KW - Recombinant Fusion Proteins
KW - Structure-Activity Relationship
KW - Talin
KW - Transfection
U2 - 10.1038/ncb2340
DO - 10.1038/ncb2340
M3 - SCORING: Journal article
C2 - 21947080
VL - 13
SP - 1315
EP - 1324
JO - NAT CELL BIOL
JF - NAT CELL BIOL
SN - 1465-7392
IS - 11
ER -